A Durable Response to Osimertinib in an Elderly Patient With EGFR T790M Positive Metastatic Non–Small-Cell Lung Cancer After Progression on Erlotinib

20233 citationsJournal Article

Authors

McKenna Blyly · Bronson Battle Creek Hospital

Abstract

1Home Stryker School of Medicine, Bronson Cancer Care Center, Battle Creek, MI 2Bronson Cancer Care Center, Battle Creek, MI The authors have no conflicts of interest to declare.

Topics & Keywords

Lung Cancer Treatments and Mutations Lung Cancer Diagnosis and Treatment Colorectal Cancer Treatments and Studies

Publication Details

Published in: American Journal of Therapeutics

Volume 30, Issue 5, pp. e463-e465

DOI: 10.1097/mjt.0000000000001598

Field-Weighted Citation Impact: 0.80

Command Palette

A Durable Response to Osimertinib in an Elderly Patient With EGFR T790M Positive Metastatic Non–Small-Cell Lung Cancer After Progression on Erlotinib

Authors

Abstract

Topics & Keywords

Publication Details